
via University of South Australia
University of South Australia researchers are a step closer to finding a new biomarker for osteoarthritis, a painful condition which affects more than two million Australians and costs the country an estimated $23 billion a year.
Using new state-of-the-art imaging techniques to identify signs of osteoarthritis (OA), UniSA scientists are learning more about changes at the molecular level which indicate the severity of cartilage damage.
A study led by PhD student Olivia Lee and her supervisor Associate Professor Paul Anderson using mass spectrometry imaging (MSI) has mapped complex sugars on OA cartilage, showing different sugars are associated with damaged tissue compared to healthy tissue.
The finding will potentially help overcome one of the main challenges of osteoarthritis research – identifying why cartilage degrades at different rates in the body.
“Despite its prevalence in the community, there is a lot about osteoarthritis that we don’t understand,” Prof Anderson says.
“It is one of the most common degenerative joint diseases, yet there are limited diagnostic tools, few treatment options and no cure.”
Existing OA biomarkers are still largely focused on bodily fluids which are neither reliable nor sensitive enough to map all the changes in cartilage damage.
By understanding the biomolecular structure at the tissue level and how the joint tissues interact in the early stages of osteoarthritis, UniSA researchers say any molecular changes could be targeted to help slow the progression of the disease with appropriate medication or treatment.
Osteoarthritis affects an estimated 2.2 million Australians and more than 300 million people worldwide, with those aged over 45 most at risk. Being female, overweight, and having existing joint injuries increases the risk of getting OA.
In Australia, $3.75 million is spent on joint replacements alone for osteoarthritis patients each year, and other indirect costs related to lost work productivity and loss of wellbeing are estimated to be more than $23 billion a year.
In a recent paper published in the International Journal of Molecular Sciences, Lee and her colleagues from UniSA’s Musculoskeletal Biology Research Laboratory and the Future Industries Institute explore how advances in mass spectrometry imaging (MSI) to detect OA are promising.
“To date, diagnosing osteoarthritis has relied heavily on x-rays or MRI, but these provide limited information and don’t detect biomolecular changes that signal cartilage and bone abnormalities,” Lee says.
“By contrast, alternative imaging methods such as MSI can identify specific molecules and organic compounds in the tissue section.”
MSI has already demonstrated its strengths in identifying biomarkers for different types of cancer, and UniSA researchers are hopeful it can achieve the same for early diagnosis of osteoarthritis.
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Osteoarthritis
- Orthopedic Implants Global Market Report 2023: Increasing Incidences of Osteoarthritis and Other Degenerative Diseases Boosts Demand
The major factors driving the growth of the orthopedic implants market are increase in incidences of osteoarthritis and other degenerative diseases, technological advancements that allow more ...
- People with allergic diseases may be at heightened risk of osteoarthritis
People with atopic (allergic) diseases like asthma or eczema may be at heightened risk of the painful and often disabling joint condition, osteoarthritis, finds research published online in the Annals ...
- Osteoarthritis Drugs Market by Product Type and Consumers-2030
What is the Osteoarthritis Drugs market growth? Osteoarthritis Drugs Market Size is projected to Reach Multimillion USD by 2028, In comparison to 2023, at unexpected CAGR during the forecast Period ...
- Risk of Developing Osteoarthritis Increased for Patients With Atopic Disease
Patients with atopic disease have an increased risk of developing osteoarthritis (OA), according to a study published online March 27 in the Annals of Rheumatic Disease. Matthew C. Baker, M.D., from ...
- The Medicine Cabinet: Ask the Harvard Experts: When knee osteoarthritis strikes at a younger age
Q: I already have osteoarthritis of my knees and I am not even 50 yet. Why do some people develop this at a younger age? Why does it cause pain? A: People with osteoarthritis have breakdown of ...
Go deeper with Google Headlines on:
Osteoarthritis
[google_news title=”” keyword=”osteoarthritis” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
Osteoarthritis biomarker
- South Warwickshire woman set to be the first diabetic woman to complete the Marathon de Sables
Charlotte Hurst is taking on the Marathon des Sables - a brutal 250km seven-day race across the Sahara desert deemed the toughest footrace in the world, which h ...
- Why Is Asthma Linked to Increased Risk of Osteoarthritis?
Drugs used to inhibit the physiological responses for allergic reactions lessen osteoarthritis risk, revealed research.
- Biomarkers show promise for identifying early risk of pancreatic cancer
A research team has identified a set of biomarkers that could help distinguish whether cysts on the pancreas are likely to develop into cancer or remain benign. A research team at Duke Health has ...
- Dr. Roach: Exercise builds strength, improves limits on those with arthritis
Dear Dr. Roach: I so appreciated your recent column on arthritis — specifically osteoarthritis. I’m a big exerciser; however, I have always heard that this arthritis is caused or exacerbated ...
- The common conditions that could be warning signs of osteoarthritis
Osteoarthritis is the most common form of arthritis and there is no cure. Analysis of healthcare records of more than a million Americans allowed the team to compare 110,000 individuals ...
Go deeper with Google Headlines on:
Osteoarthritis biomarker
[google_news title=”” keyword=”osteoarthritis biomarker” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]